Literature DB >> 11700957

5,7-Dihydroxytryptamine: regional brain concentrations following intraventricular administration to rats.

S J Choi1, V Patil, J D Fernstrom.   

Abstract

The concentrations of 5,7-dihydroxytryptamine (5,7-DHT) and serotonin (5-HT) were measured in brainstem, hypothalamus and cerebral cortex 0, 2, 6, 12, and 24 hours following the bilateral, lateral ventricular injection of 5,7-DHT (100 microg/each ventricle) into adult male rats. At 6 hours, 5,7-DHT levels had decreased 99% from 0 hr values in all brain regions. Thereafter, 5,7-DHT levels continued to decline in cortex, but not in hypothalamus or brainstem; at 24 hr, but not 48 hr, 5,7-DHT peaks were still measurable in each brain region examined. Serotonin levels in all three regions also fell markedly by 2-6 hours after 5,7-DHT administration. At 24 hours, hypothalamus and brainstem 5HT levels had declined >70% and cerebral cortex approximately 50% below control values. The relevance of these findings to the protective action of monoamine reuptake blockers is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700957     DOI: 10.1023/a:1012374923662

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  17 in total

1.  Dihydroxytryptamines: effects on noradrenergic function in mouse heart in vivo.

Authors:  C R Creveling; J Lundstrom; E T McNeal; L Tice; J W Daly
Journal:  Mol Pharmacol       Date:  1975-03       Impact factor: 4.436

2.  5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine.

Authors:  A Björklund; H G Baumgarten; A Rensch
Journal:  J Neurochem       Date:  1975-04       Impact factor: 5.372

Review 3.  Mode and mechanism of action of neurotoxic indoleamines: a review and a progress report.

Authors:  H G Baumgarten; H P Klemm; L Lachenmayer; A Björklund; W Lovenberg; H G Schlossberger
Journal:  Ann N Y Acad Sci       Date:  1978-06-12       Impact factor: 5.691

4.  Chemical lesioning of central monoamine axons by means of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine.

Authors:  A Björklund; H G Baumgarten; A Nobin
Journal:  Adv Biochem Psychopharmacol       Date:  1974

5.  Regeneration of central serotonin neurons after axonal degeneration induced by 5,6-dihydroxytryptamine.

Authors:  A Björklund; A Nobin; U Stenevi
Journal:  Brain Res       Date:  1973-02-14       Impact factor: 3.252

6.  Neurochemical effects of serotonin neurotoxins: an introduction.

Authors:  R W Fuller
Journal:  Ann N Y Acad Sci       Date:  1978-06-12       Impact factor: 5.691

7.  The effect of intracerebral injections of 5,7-dihydroxytryptamine and 6-hydroxydopamine on the serotonin-immunoreactive cell bodies and fibers in the adult rat hypothalamus.

Authors:  M Frankfurt; E Azmitia
Journal:  Brain Res       Date:  1983-02-14       Impact factor: 3.252

8.  Polarographic measurements of spontaneous and mitochondria-promoted oxidation of 5,6- and 5,7-dihydroxytryptamine.

Authors:  H P Klemm; H G Baumgarten; H G Schlossberger
Journal:  J Neurochem       Date:  1980-12       Impact factor: 5.372

9.  Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo.

Authors:  M T O'Connell; C M Portas; G S Sarna; G Curzon
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

10.  Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats.

Authors:  G R Breese; B R Cooper
Journal:  Brain Res       Date:  1975-11-21       Impact factor: 3.252

View more
  1 in total

1.  Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task.

Authors:  M V King; C H Spicer; A J Sleight; C A Marsden; K C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2008-10-07       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.